H-Index
79
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
15%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo

Medical Science Monitor Basic Research
AmJCaseRep

Annals
ISI-Home

eISSN: 1643-3750

Proinflammation and preconditioning protection are part of a common nitric oxide mediated process

George B. Stefano, Tobias Esch, Thomas V. Bilfinger, Richard M. Kream

Med Sci Monit 2010; 16(6): RA125-130

ID: 880600

Available online: 2010-06-01

Published: 2010-06-01


#880600

In the pathophysiology of many different diseases, proinflammatory disease processes repeatedly seem to represent a basic principle. Proinflammation, as any biologic process, has the capacity of exerting negative effects, since its components are toxic and autotoxic. Since proinflammation is a common phenomenon and is, capable of executing negative ‘side effects’, it is understandable and plausible why it seems to be involved in many different disease states. The different clinical manifestations of proinflammation (different diseases) may actually represent a common and consistent pathophysiological entity that is not separable by its molecular implications. Simultaneously, preconditioning protection counter-intuitively may rely on the same molecular process involving nitric oxide as a chemical messenger.

Keywords: Morphine - pharmacology, Nitric Oxide - metabolism, Models, Biological, Mitochondria - metabolism, Inflammation, Immune System - physiology, Dopamine - metabolism, Catecholamines - metabolism, Animals, Nitric Oxide Synthase Type II - metabolism, Signal Transduction



Back